Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 2Withdrawn 1Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphatic Metastasis 1

Interventions

toripalimab 1tislelizumab 1pembrolizumab 1ibrutinib 1fludarabine 1dynorphin-converting endopeptidase 1Spinal Puncture 1Propranolol 1Positron-Emission Tomography 1Nivolumab 1Magnetic Resonance Imaging 1JNJ-64619178 1JNJ-64264681 1Gemcitabine 1Dexamethasone 1Deoxycholic Acid 1Cyclophosphamide 1Cisplatin 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Enrolling by invitation × Propranolol × Clear all
NCT07353294 2026-04-22

Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 1 Enrolling by invitation
12 enrolled

Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡